相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。BRCA1 and BRCA2 Germline Mutations Are Frequently Demonstrated in Both High-Risk Pancreatic Cancer Screening and Pancreatic Cancer Cohorts
Aimee L. Lucas et al.
CANCER (2014)
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
Lola Rahib et al.
CANCER RESEARCH (2014)
The Early Detection of Pancreatic Cancer: What Will It Take to Diagnose and Treat Curable Pancreatic Neoplasia?
Anne Marie Lennon et al.
CANCER RESEARCH (2014)
High Prevalence of BRCA1 and BRCA2 Germline Mutations with Loss of Heterozygosity in a Series of Resected Pancreatic Adenocarcinoma and Other Neoplastic Lesions
Aimee L. Lucas et al.
CLINICAL CANCER RESEARCH (2013)
International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer
Marcia Irene Canto et al.
GUT (2013)
Identifying people at a high risk of developing pancreatic cancer
Alison P. Klein
NATURE REVIEWS CANCER (2013)
Exome sequencing identifies nonsegregating nonsense ATM and PALB2 variants in familial pancreatic cancer
Robert C. Grant et al.
HUMAN GENOMICS (2013)
The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers
J. Iqbal et al.
BRITISH JOURNAL OF CANCER (2012)
Prevalence of BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and pancreatic cancer
Zsofia K. Stadler et al.
CANCER (2012)
Clinical significance of large rearrangements in BRCA1 and BRCA2
Thaddeus Judkins et al.
CANCER (2012)
Routine testing for PALB2 mutations in familial pancreatic cancer families and breast cancer families with pancreatic cancer is not indicated
Femme Harinck et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2012)
Indication for CDKN2A-mutation analysis in familial pancreatic cancer families without melanomas
Femme Harinck et al.
JOURNAL OF MEDICAL GENETICS (2012)
Genetic susceptibility to pancreatic cancer
Alison P. Klein
MOLECULAR CARCINOGENESIS (2012)
Prevalence of CDKN2A mutations in pancreatic cancer patients: implications for genetic counseling
Robert R. McWilliams et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2011)
Therapeutic Potential of Poly(ADP-ribose) Polymerase Inhibitor AG014699 in Human Cancers With Mutated or Methylated BRCA1 or BRCA2
Yvette Drew et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
An Emerging Entity: Pancreatic Adenocarcinoma Associated with a Known BRCA Mutation: Clinical Descriptors, Treatment Implications, and Future Directions
Maeve A. Lowery et al.
ONCOLOGIST (2011)
Pancreatic Cancer Screening in a Prospective Cohort of High-Risk Patients: A Comprehensive Strategy of Imaging and Genetics
Elizabeth C. Verna et al.
CLINICAL CANCER RESEARCH (2010)
PALB2 mutations in European familial pancreatic cancer families
E. P. Slater et al.
CLINICAL GENETICS (2010)
Absence of germline BRCA1 mutations in familial pancreatic cancer patients
Jennifer E. Axilbund et al.
CANCER BIOLOGY & THERAPY (2009)
Polymorphic Variants in Hereditary Pancreatic Cancer Genes Are Not Associated with Pancreatic Cancer Risk
Robert R. McWilliams et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Five years of prospective screening of high-risk individuals from families with familial pancreatic cancer
P. Langer et al.
GUT (2009)
Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility Gene
Sian Jones et al.
SCIENCE (2009)
ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007
C. Sue Richards et al.
GENETICS IN MEDICINE (2008)
Germline BRCA1 mutations predispose to pancreatic adenocarcinoma
Wigdan Al-Sukhni et al.
HUMAN GENETICS (2008)
Fanconi anemia is associated with a defect in the BRCA2 partner PALB2
Bing Xia et al.
NATURE GENETICS (2007)
The prevalence of BRCA2 mutations in familial pancreatic cancer
Fergus J. Couch et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2
Bing Xia et al.
MOLECULAR CELL (2006)
Pancreatic cancer genetic epidemiology consortium
GM Petersen et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Prevalence of five previously reported and recurrent BRCA1 genetic rearrangement mutations in 20,000 patients from hereditary breast/ovarian cancer families
BC Hendrickson et al.
GENES CHROMOSOMES & CANCER (2005)
BRCA1 and pancreatic cancer:: pedigree findings and their causal relationships
HT Lynch et al.
CANCER GENETICS AND CYTOGENETICS (2005)
Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds
AP Klein et al.
CANCER RESEARCH (2004)
CDKN2A germline mutations in familial pancreatic cancer
DK Bartsch et al.
ANNALS OF SURGERY (2002)
Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2:: Analysis of 10,000 individuals
TS Frank et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
分享论文
